Comments
Loading...

Sage Therapeutics

SAGENASDAQ
Logo brought to you by Benzinga Data
$5.67
-0.22-3.74%
At close: -
$5.67
0.000.00%
After Hours: 4:11 PM EDT

Sage Therapeutics (NASDAQ:SAGE) Stock, Earnings Estimates, EPS, And Revenue

Sage Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 12
EPS Estimate
$-1.520
Quarterly Revenue Estimate
$12.5M
Annual Revenue
(as of Sep 30)
$106.4M

Analyze the earnings history of Sage Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Sage Therapeutics (SAGE) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-10-29$-1.53$-1.530.00 %
Jun 20242024-07-31$-1.70$-1.66-2.41 %
Mar 20242024-04-25$-1.80$-1.65-9.09 %
Dec 20232024-02-14$-0.55$-1.2857.0 %

Sage Therapeutics (SAGE) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Sep 20242024-10-29$11.87M$10.80M9.92 %
Jun 20242024-07-31$8.65M$8.85M-2.19 %
Mar 20242024-04-25$7.90M$5.66M39.6 %
Dec 20232024-02-14$77.97M$60.98M27.9 %

FAQ

Q

When is Sage Therapeutics (NASDAQ:SAGE) reporting earnings?

A

Sage Therapeutics (SAGE) is scheduled to report earnings on February 12, 2025. The last reported earnings were for reported on October 29, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Sage Therapeutics (NASDAQ:SAGE)?

A

The Actual EPS was $-1.53, which hit the estimate of $-1.53.

Q

What were Sage Therapeutics’s (NASDAQ:SAGE) revenues?

A

The Actual Revenue was $11.9M, which beat the estimate of $10.8M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch